日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pyruvate kinase muscle 2 (PKM2) promotes CD4 T cell survival by regulating pyruvate oxidation during homeostasis and expansion.

丙酮酸激酶肌肉 2 (PKM2) 通过在稳态和扩增过程中调节丙酮酸氧化来促进 CD4 T 细胞存活。

Subleski Jeff J, Palmieri Erika M, Walls Jessica F, Hsu Steven, Bettencourt Ian A, Gower Timothy R, Durum Scott K, McVicar Daniel W

Serum-based tracking of de novo initiated liver cancer progression reveals early immunoregulation and response to therapy

基于血清的肝癌新发病进展追踪揭示了早期免疫调节和治疗反应。

Subleski, Jeff J; Scarzello, Anthony J; Alvord, W Gregory; Jiang, Qun; Stauffer, Jimmy K; Kronfli, Anthony; Saleh, Bahara; Back, Timothy; Weiss, Jonathan M; Wiltrout, Robert H

IFN-gamma AU-rich element removal promotes chronic IFN-gamma expression and autoimmunity in mice.

IFN-γ AU 富集元件的去除促进小鼠慢性 IFN-γ 表达和自身免疫

Hodge Deborah L, Berthet Cyril, Coppola Vincenzo, Kastenmüller Wolfgang, Buschman Matthew D, Schaughency Paul M, Shirota Hidekazu, Scarzello Anthony J, Subleski Jeff J, Anver Miriam R, Ortaldo John R, Lin Fanching, Reynolds Della A, Sanford Michael E, Kaldis Philipp, Tessarollo Lino, Klinman Dennis M, Young Howard A

TCR-dependent and -independent activation underlie liver-specific regulation of NKT cells.

NKT细胞的肝脏特异性调控依赖于TCR依赖性和非依赖性激活

Subleski Jeff J, Hall Veronica L, Wolfe Thomas B, Scarzello Anthony J, Weiss Jonathan M, Chan Tim, Hodge Deborah L, Back Timothy C, Ortaldo John R, Wiltrout Robert H

Immunotherapy of cancer by IL-12-based cytokine combinations

基于IL-12的细胞因子组合免疫疗法治疗癌症

Weiss, Jonathan M; Subleski, Jeff J; Wigginton, Jon M; Wiltrout, Robert H